Global Liquid Biopsy Market

Focus on Products and Services, Therapeutic Applications, Clinical Applications, Circulating Biomarkers, Country Analysis (16 Countries), Industry Insights, and Competitive Landscape - Analysis and Forecast, 2018-2028

Published Year: 2018
SKU: BHP0530SB

5000

Online Access for 1-3 Users. Permission to Print.


In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

A quick peek into the report

Table of Contents

Download this TOC  

Request a Sample

Market Overview

        1.1   Historical Trends
        1.2   Comparative Analysis of Tissue Biopsy and Liquid Biopsy
        1.3   Clinical Applications of Liquid Biopsy
        1.4   Trends for Liquid Biopsy
        1.5   Assumptions and Limitations for Market Size Calculations
        1.6   Global Liquid Biopsy Market Scenario

Market Dynamics

        2.1   Impact Analysis
        2.2   Market Drivers
                2.2.1   Potential of Liquid Biopsy
                2.2.2   Ability to Monitor Clonal Mutations
                2.2.3   Growing Prominence of Precision Medicine
        2.3   Market Restraints
                2.3.1   Uncertain Reimbursement and Regulatory Policies
                2.3.2   High Pricing Pressure
                2.3.3   Adoption of Traditional Diagnosis Practices
        2.4   Market Opportunities
                2.4.1   Development of Medication Package Deals
                2.4.2   Expansion into Emerging markets
                2.4.3   Scope of Liquid Biopsy for Intervention: Diagnosis of Non-oncology Disorders

Competitive Insights

        3.1   Key Strategies and Developments
                3.1.1   Mergers and Acquisitions
                3.1.2   Business Expansions
                3.1.3   Awards, Recognitions, Certifications, and Others
                3.1.4   Product Launches and Enhancements
                3.1.5   Joint Ventures, Partnerships, and Collaborations
        3.2   Market Share Analysis
        3.3   Growth Share Analysis
                3.3.1   Growth Share Analysis (by Prominent Companies)
                3.3.2   Growth Share Analysis (by Therapeutic Application)
                3.3.3   Growth Share Analysis (by Biomarker Type)
                3.3.4   Growth Share Analysis (by Clinical Application)
        3.4   Global Comprehensive Competitive Index (CCI)
        3.5   Industry Attractiveness
                3.5.1   Bargaining Power of Suppliers
                3.5.2   Bargaining Power of Buyer
                3.5.3   Threat of New Entrants
                3.5.4   Threat of Substitute Products
                3.5.5   Intensity of Competitive Rivalry

Industry Insights

        4.1   Introduction
        4.2   Patent Analysis
        4.3   Funding Scenario
        4.4   Regulatory Bodies
        4.5   Clinical Laboratory Improvement Amendments (CLIA) Program
        4.6   Government Initiatives

Global Liquid Biopsy Market (by Circulating Biomarkers)

        5.1   Circulating Tumor DNA (cTDNA)
        5.2   Circulating Tumor Cells (CTCs)
        5.3   Cell-Free DNA (cfDNA)
        5.4   Extracellular Vesicles and Others

Global Liquid Biopsy Market (by Products)

        6.1   Tests/Services
        6.2   Kits and Consumables
        6.3   Instruments

Global Liquid Biopsy Market (by Therapeutic Application)

        7.1   Lung Cancer
        7.2   Breast Cancer
        7.3   Prostate Cancer
        7.4   Colorectal Cancer
        7.5   Melanoma Cancer
        7.6   Other Types of Cancer
        7.7   Non-Oncology Application

Global Liquid Biopsy Market (by Clinical Applications)

        8.1   Treatment Monitoring
        8.2   Prognosis and Reoccurrence Monitoring
        8.3   Treatment Selection
        8.4   Diagnosis and Screening

Global Liquid Biopsy Market (by Region)

        9.1   Analysis of Growth Potential of Different Countries: Global Liquid Biopsy Market
                9.1.1   Cluster-1: China and India
                9.1.2   Cluster-2: The U.S. and Japan
                9.1.3   Cluster-3: Brazil, South Korea, Spain, Italy, The U.K., France, and Canada
                9.1.4   Cluster-4: Germany, Australia, Singapore, Mexico, and Saudi Arabia
        9.2   North America
                9.2.1   The U.S.
                           9.2.1.1   U.S. Liquid Biopsy Market (by Therapeutic Application)
                9.2.2   Canada
                           9.2.2.1   Canada Liquid Biopsy Market (by Therapeutic Application)
        9.3   Europe
                9.3.1   Germany
                           9.3.1.1   Germany Liquid Biopsy Market (by Therapeutic Application)
                9.3.2   France
                           9.3.2.1   France Liquid Biopsy Market (by Therapeutic Application)
                9.3.3   The U.K.
                            9.3.3.1   U.K. Liquid Biopsy Market (by Therapeutic Application)
                 9.3.4   Italy
                            9.3.4.1   Italy Liquid Biopsy Market (by Therapeutic Application)
                 9.3.5   Spain
                            9.3.5.1   Spain Liquid Biopsy Market (by Therapeutic Application)
                 9.3.6   Rest-of-Europe
        9.4   Asia-Pacific
                9.4.1   China
                           9.4.1.1   China Liquid Biopsy Market (by Therapeutic Application)
                9.4.2   Japan
                           9.4.2.1   Japan Liquid Biopsy Market (by Therapeutic Application)
                9.4.3   India
                           9.4.3.1   India Liquid Biopsy Market (by Therapeutic Application)
                9.4.4   Australia
                           9.4.4.1   Australia Liquid Biopsy Market (by Therapeutic Application)
                9.4.5   South Korea
                           9.4.5.1   South Korea Liquid Biopsy Market (by Therapeutic Application)
                9.4.6   Singapore
                           9.4.6.1   Singapore Liquid Biopsy Market (by Therapeutic Application)
                9.4.7   Rest-of-Asia-Pacific
        9.5   Latin America and Middle East
                9.5.1   Brazil
                           9.5.1.1   Brazil Liquid Biopsy Market (by Therapeutic Application)
               9.5.2   Mexico
                          9.5.2.1   Mexico Liquid Biopsy Market (by Therapeutic Application)
               9.5.3   Saudi Arabia
                          9.5.3.1   Saudi Arabia Liquid Biopsy Market (by Therapeutic Application)
               9.5.4   Rest-of-Latin America and Middle East
        9.6  Rest-of-the-World

Company Profiles

          10.1   Overview
          10.2   Abcodia Ltd.
                     10.2.1   Company Overview
                     10.2.2   Role of Abcodia Ltd. in the Liquid Biopsy Market
                     10.2.3   SWOT Analysis
          10.3   Adaptive Biotechnologies
                   10.3.1   Company Overview
                   10.3.2   Role of Adaptive Biotechnologies Corporation in the Liquid Biopsy Market
                   10.3.3   SWOT Analysis
          10.4   ANGLE plc
                    10.4.1   Company Overview
                    10.4.2   Role of ANGLE plc in the Liquid Biopsy Market
                    10.4.3   Financials
                                 10.4.3.1   Key Insights on the Financial Health of the Company
                    10.4.4   Global Presence
                    10.4.5   SWOT Analysis
          10.5   Biocept, Inc.
                    10.5.1   Company Overview
                    10.5.2   Role of Biocept, Inc. in Liquid Biopsy Market
                    10.5.3   Financials
                    10.5.4   Key Insights about Financial Health of the Company
                    10.5.5   SWOT Analysis
          10.6   Bio-Rad Laboratories, Inc.
                    10.6.1   Company Overview
                    10.6.2   Role of Bio-Rad Laboratories, Inc. in Liquid Biopsy Market
                    10.6.3   Financials
                    10.6.4   Key Insights about Financial Health of the company
                    10.6.5   Global Presence
                    10.6.6   SWOT Analysis
          10.7   Cynvenio Biosystems, Inc.
                    10.7.1   Company Overview
                    10.7.2   Role of Cynvenio Biosystems, Inc. in the Liquid Biopsy Market
                    10.7.3   SWOT Analysis
          10.8   Chronix Biomedical
                    10.8.1   Company Overview
                    10.8.2   Role of Chronix Biomedical in the Liquid Biopsy Market
                    10.8.3   SWOT Analysis
          10.9   Epic Sciences, Inc.
                    10.9.1   Company Overview
                    10.9.2   Role of Epic Sciences, Inc. in the Liquid Biopsy in the Market
                    10.9.3   SWOT Analysis
          10.10   F. Hoffmann-La Roche AG
                    10.10.1   Company Overview
                    10.10.2   Role of F. Hoffmann-La Roche AG in the Liquid Biopsy Market
                    10.10.3   Financials
                    10.10.4   Key Insights about Financial Health of the company
                    10.10.5   Global Presence
                    10.10.6   SWOT Analysis
         10.11  GUARDANT HEALTH, INC
                    10.11.1   Company Overview
                    10.11.2   Role of GUARDANT HEALTH, Inc. in Liquid Biopsy Market
                    10.11.3   SWOT Analysis
          10.12  Illumina, Inc.
                     10.12.1   Company Overview
                     10.12.2   Role of Illumina, Inc. in the Liquid Biopsy Market
                     10.12.3   Financials
                     10.12.4   Key Insights about Financial Health of the Company
                     10.12.5   Global Presence
                     10.12.6   SWOT Analysis
          10.13  MDxHealth, Inc.
                     10.13.1   Company Overview
                     10.13.2   Role of MDxHealth, Inc. in the Liquid Biopsy Market
                     10.13.3   Financials
                     10.13.4   Key Insights on the Financial Health of the Company
                     10.13.5   Global Presence
                     10.13.6   SWOT Analysis
          10.14  Menarini Silicon Biosystems, Inc.
                     10.14.1   Company Overview
                     10.14.2   Role of Menarini Silicon Biosystems in the Liquid Biopsy Market
                     10.14.3   SWOT Analysis
          10.15  Myriad Genetics, Inc.
                     10.15.1   Company Overview
                     10.15.2   Role of Myriad Genetics, Inc. in Liquid Biopsy Market
                     10.15.3   Financials
                                    10.15.3.1   Key Insights of the Financial Health of the Company
                     10.15.4   Global Presence
                     10.15.5   SWOT Analysis
          10.16  Natera, Inc.
                    10.16.1   Company Overview
                    10.16.2   Role of Natera, Inc. in the Liquid Biopsy Market
                    10.16.3   Financials
                                   10.16.3.1   Key Insights of the Financial Health about the Company
                    10.16.4   Global Presence
                    10.16.5   SWOT Analysis
          10.17  NeoGenomics Laboratories, Inc.
                     10.17.1   Company Overview
                     10.17.2   Role of NeoGenomics Laboratories, Inc. in the Liquid Biopsy Market
                     10.17.3   Financials
                                    10.17.3.1   Key Insights on the Financial Health of the Company
                     10.17.4   Global Presence
                     10.17.5   SWOT Analysis
          10.18  Personal Genome Diagnostics, Inc.
                     10.18.1   Company Overview
                     10.18.2   Role of Personal Genome Diagnostics, Inc. in Liquid Biopsy Market
                     10.18.3   SWOT Analysis
          10.19  Qiagen N.V.
                     10.19.1   Company Overview
                     10.19.2   Role of Qiagen N.V. in the Liquid Biopsy Market
                     10.19.3   Financials
                                    10.19.3.1   Key Insights on the Financial Health of the Company
                     10.19.4   Global Presence
                     10.19.5   SWOT Analysis
          10.20  Resolution Bioscience, Inc.
                     10.20.1   Company Overview
                     10.20.2   Role of Resolution Biosciences, Inc. in the Liquid Biopsy Market
                     10.20.3   SWOT Analysis
          10.21  Sysmex Corporation
                     10.21.1   Company Overview
                     10.21.2   Role of Sysmex Corporation in the Liquid Biopsy Market
                     10.21.3   Financials
                     10.21.4   Key Insights of the Financial Health of the Company
                     10.21.5   Global Presence
                     10.21.6   SWOT Analysis
          10.22  Thermo Fisher Scientific
                     10.22.1   Company Overview
                     10.22.2   Role of Thermo Fisher Scientific in the Liquid Biopsy Market
                     10.22.3   Financials
                                    10.22.3.1   Key Insights on the Financial Health of the Company
                     10.22.4   Global Presence
                     10.22.5   SWOT Analysis

Research Scope and Methodology

          11.1   Report Scope
          11.2   Global Liquid Biopsy Market: Research Methodology

List of Tables

Table 1    Cancer Incidences (by Region), 2015
Table 1.1    Tissue Biopsy vs. Liquid Biopsy
Table 2.1    Impact Analysis
Table 2.2    Governmental Initiatives for the Market Growth of Precision Medicine
Table 2.3    Incidence of Leading Cancer Types (by Region), 2015
Table 4.1    List of Regulatory Bodies across the World
Table 4.2    List of Regulatory Authorities involved in CLIA Program
Table 4.3    Government Initiatives
Table 7.1    Lung Cancer Incidence in Top Countries, 2012-2030
Table 7.2    Breast Cancer Incidence in Top Countries, 2012-2030
Table 7.3    Prostate Cancer Incidence in Top Countries, 2012-2030
Table 7.4    Colorectal Cancer Incidence in Top Countries, 2012-2030
Table 7.5    Estimated Incidence and Mortality of Melanoma Worldwide in 2012
Table 7.6    Melanoma Cancer Incidence in Top Countries, 2012-2030
Table 7.7    Ovarian Cancer Incidence in Top Countries, 2012-2030
Table 7.8    Stomach Cancer Incidence in Top Countries, 2012-2030
Table 9.1    Analysis of Growth Potential (by Countries)
Table 9.2    Prevalence of Different Types of Cancer (by Country), 2017
Table 9.3    Prevalence of Different Types of Cancer (by Country), 2017
Table 9.4    The U.S: Prevalence of Different Types of Cancer, 2015-2030
Table 9.5    Canada: Prevalence of Different Types of Cancer, 2015-2030
Table 9.6    Germany: Prevalence of Different Types of Cancer, 2015-2030
Table 9.7    France: Prevalence of Different Types of Cancer, 2015-2030
Table 9.8    The U.K.: Prevalence of Different Types of Cancer, 2015-2030
Table 9.9    Italy: Prevalence of Different Types of Cancer, 2015-2030
Table 9.10    Spain: Prevalence of Different Types of Cancer, 2015-2030
Table 9.11    China: Prevalence of Different Types of Cancer, 2015-2030
Table 9.12    Japan: Prevalence of Different Types of Cancer, 2015-2030
Table 9.13    India: Prevalence of Different Types of Cancer, 2015-2030
Table 9.14    Australia: Prevalence of Different Types of Cancer, 2015-2030
Table 9.15    South Korea: Prevalence of Different Types of Cancer, 2015-2030
Table 9.16    Singapore: Prevalence of Different Types of Cancer, 2015-2030
Table 9.17    Brazil: Prevalence of Different Types of Cancer, 2015-2030
Table 9.18    Mexico: Prevalence of Different Types of Cancer, 2015-2030
Table 9.19    Saudi Arabia: Prevalence of Different Types of Cancer, 2015-2030

List of Figures

Figure 1    Few Citations of Liquid Biopsy
Figure 2    Facts about Cancer
Figure 3    Market Drivers and Market Restraints
Figure 4    Market Statistics
Figure 5    Global Liquid Biopsy Market, 2017-2028
Figure 6    Global Liquid Biopsy Market (by Products), 2017 and 2028
Figure 7    Global Liquid Biopsy Market (by Circulating Biomarker), 2017-2028
Figure 8    Global Liquid Biopsy Market (by Clinical Application), 2017-2028
Figure 9    Global Liquid Biopsy Market (by Therapeutic Application), 2017-2028
Figure 10    Global Liquid Biopsy Market (by Region), 2017-2028
Figure 11    Adoption Rate: Tissue Biopsy vs. Liquid biopsy
Figure 1.1    Different Types of Biomarkers in Liquid Biopsy
Figure 1.2    Evolution of Liquid Biopsy with Progress in Molecular Technologies and Biomarker Discovery
Figure 1.3    Workflow Model of Tissue and Liquid Biopsy
Figure 1.4    Clinical Applications of Liquid Biopsy
Figure 1.5    Global Liquid Biopsy Market, 2017-2028
Figure 2.1    Market Dynamics of Global Liquid Biopsy Market
Figure 3.1    Competitive Landscape, January 2015-July 2018
Figure 3.2    Share of Key Developments and Strategies, January 2015-July 2018
Figure 3.3    Mergers and Acquisitions Share (by Companies), January 2015-July 2018
Figure 3.4    Business Expansions Share (by Companies), January 2015-July 2018
Figure 3.5    Awards, Recognitions, Certifications and Others Share (by Companies), January 2015-July 2018
Figure 3.6    Product Launches Share (by Companies), January 2015-July 2018
Figure 3.7    Joint Ventures, Partnerships, and Collaborations Share (by Companies), January 2015-July 2018
Figure 3.8    Market Share Analysis: Global Liquid Biopsy Market, 2016 and 2017
Figure 3.9    Growth Share Matrix for Global Liquid Biopsy Market (by Prominent Companies), 2018-2020
Figure 3.10    Growth Share Matrix for Global Liquid Biopsy Market (by Therapeutic Application), 2017
Figure 3.11    Growth Share Matrix for Global Liquid Biopsy Market (by Biomarker Type), 2017
Figure 3.12    Growth Share Matrix for Global Liquid Biopsy Market (by Clinical Application), 2017
Figure 3.13    Global Comprehensive Competitive Index (by Market Leaders), 2017
Figure 3.14    Porter’s Five Forces Analysis
Figure 3.15    Bargaining Power of Suppliers: Overall Impact, 2014-2028
Figure 3.16    Bargaining Power of Buyers: Overall Impact, 2014-2028
Figure 3.17    Threat of New Entrant: Overall Impact, 2014-2028
Figure 3.18    Threat of Substitute Products: Overall Impact, 2014-2028
Figure 3.19    Intensity of Competitive Rivalry: Overall Impact, 2014-2028
Figure 4.1    Industry Insights, January 2015-May 2018
Figure 4.2    Patent Share (by Assignee), January 2015-July 2018
Figure 4.3    Research Investments by Companies, $Million, January 2015-Decemeber 2017
Figure 4.4    Categorization of Test Methods (by FDA)
Figure 5.1    Different Circulating Biomarkers
Figure 5.2    Global Liquid Biopsy Market (by Circulating Biomarker), 2017 and 2028
Figure 5.3    Global Liquid Biopsy Market (by cTDNA), 2017-2028
Figure 5.4    CTCs vs. cTDNA Analysis
Figure 5.5    Global Liquid Biopsy Market (by CTCs), 2017-2028
Figure 5.6    Global Liquid Biopsy Market (by cfDNA), 2017-2028
Figure 5.7    Global Liquid Biopsy Market (by Extracellular Vesicles and Others), 2017-2028
Figure 6.1    Global Liquid Biopsy Market (by Products)
Figure 6.2    Global Liquid Biopsy Market (by Products), 2017-2028
Figure 6.3    Global Liquid Biopsy Market (by Tests/Services), 2017-2028
Figure 6.4    Global Liquid Biopsy Market (by Kits and Consumables), 2017-2028
Figure 6.5    Global Liquid Biopsy Market (by Instruments), 2017-2028
Figure 7.1    Global Liquid Biopsy Market (by Therapeutic Application)
Figure 7.2    Global Liquid Biopsy Market (by Therapeutic Applications), 2017-2028
Figure 7.3    Types of Lung Cancer
Figure 7.4    Global Liquid Biopsy Market (by Lung Cancer), 2017-2028
Figure 7.5    Types of Breast Cancer
Figure 7.6    Global Liquid Biopsy Market (by Breast Cancer), 2017-2028
Figure 7.7    Global Liquid Biopsy Market (by Prostate Cancer), 2017-2028
Figure 7.8    Global Liquid Biopsy Market (by Colorectal Cancer), 2017-2028
Figure 7.9    Global Liquid Biopsy Market (by Melanoma Cancer), 2017-2028
Figure 7.10    Global Liquid Biopsy Market (by Other Types of Cancer), 2017-2028
Figure 7.11    Global Liquid Biopsy Market (by Non-Oncology Applications), 2017-2028
Figure 8.1    Global Liquid Biopsy Market (by Clinical Applications)
Figure 8.2    Global Liquid Biopsy Market (by Clinical Applications), 2017-2028
Figure 8.3    Global Liquid Biopsy Market (by Treatment Monitoring), 2017-2028
Figure 8.4    Global Liquid Biopsy Market (by Prognosis and Reoccurrence Monitoring), 2017-2028
Figure 8.5    Global Liquid Biopsy Market (by Treatment Selection), 2017-2028
Figure 8.6    Global Liquid Biopsy Market (by Diagnosis and Screening), 2017-2028
Figure 9.1    Global Liquid Biopsy Market Scenario, 2017 and 2028
Figure 9.2    Global Liquid Biopsy Market (by Region), 2017-2028
Figure 9.3    Global Liquid Biopsy Market Share (by Region), 2017 and 2028
Figure 9.4    Cluster Analysis: Global Liquid Biopsy Market
Figure 9.5    Compound Annual Growth Rate of Liquid Biopsy Market (by Country), 2018-2028
Figure 9.6    Compound Annual Growth Rate of Liquid Biopsy Market (by Country), 2018-2028
Figure 9.7    Compound Annual Growth Rate of Liquid Biopsy Market (by Country), 2018-2028
Figure 9.8    Compound Annual Growth Rate of Liquid Biopsy Market (by Country), 2018-2028
Figure 9.9    North America: Liquid Biopsy Market, (2017-2028)
Figure 9.10    North America: Market Dynamics
Figure 9.11    North America: Liquid biopsy Market (by Country), 2017-2028
Figure 9.12    The U.S: Liquid Biopsy Market, 2017-2028
Figure 9.13    The U.S: Liquid Biopsy Market (by Therapeutic Application), 2017-2028
Figure 9.14    Canada: Liquid Biopsy Market, 2017-2028
Figure 9.15    Canada: Liquid Biopsy Market (by Therapeutic Application), 2017-2028
Figure 9.16    Europe: Liquid Biopsy Market, 2017-2028
Figure 9.17    Europe: Market Dynamics
Figure 9.18    Europe: Liquid Biopsy Market (by Country), 2017-2028
Figure 9.19    Germany: Liquid Biopsy Market, 2017-2028
Figure 9.20    Germany: Liquid Biopsy Market (by Therapeutic Application), 2017-2028
Figure 9.21    France: Liquid Biopsy Market, 2017-2028
Figure 9.22    France: Liquid Biopsy Market (by Therapeutic Application), 2017-2028
Figure 9.23    The U.K.: Liquid Biopsy Market, 2017-2028
Figure 9.24    The U.K.: Liquid Biopsy Market (by Therapeutic Application), 2017-2028
Figure 9.25    Italy: Liquid Biopsy Market, 2017-2028
Figure 9.26    Italy: Liquid Biopsy Market (by Therapeutic Application), 2017-2028
Figure 9.27    Spain: Liquid Biopsy Market, 2017-2028
Figure 9.28    Spain: Liquid Biopsy Market (by Therapeutic Application), 2017-2028
Figure 9.29    Rest-of-Europe: Liquid Biopsy Market, 2017-2028
Figure 9.30    Asia-Pacific: Liquid Biopsy Market, 2017-2028
Figure 9.31    Asia-Pacific: Market Dynamics
Figure 9.32    Asia Pacific: Liquid Biopsy Market (by Country), 2017-2028
Figure 9.33    China: Liquid Biopsy Market, 2017-2028
Figure 9.34    China: Liquid Biopsy Market (by Therapeutic Application), 2017-2028
Figure 9.35    Japan: Liquid Biopsy Market, 2017-2028
Figure 9.36    Japan: Liquid Biopsy Market (by Therapeutic Application), 2017-2028
Figure 9.37    India: Liquid Biopsy Market, 2017-2028
Figure 9.38    India: Liquid Biopsy Market (by Therapeutic Application), 2017-2028
Figure 9.39    Australia: Liquid Biopsy Market, 2017-2028
Figure 9.40    Australia: Liquid Biopsy Market (by Therapeutic Application), 2017-2028
Figure 9.41    South Korea: Liquid Biopsy Market, 2017-2028
Figure 9.42    South Korea: Liquid Biopsy Market (by Therapeutic Application), 2017-2028
Figure 9.43    Singapore: Liquid Biopsy Market, 2017-2028
Figure 9.44    Singapore: Liquid Biopsy Market (by Therapeutic Application), 2017-2028
Figure 9.45    Rest-of-Asia Pacific: Liquid Biopsy Market, 2017-2028
Figure 9.46    Latin America: Liquid Biopsy Market, 2017-2028
Figure 9.47    Latin America: Market Dynamics
Figure 9.48    Latin America: Liquid Biopsy Market (by Country), 2017-2028
Figure 9.49    Brazil: Liquid Biopsy Market, 2017-2028
Figure 9.50    Brazil: Liquid Biopsy Market (by Therapeutic Application), 2017-2028
Figure 9.51    Mexico: Liquid Biopsy Market, 2017-2028
Figure 9.52    Mexico: Liquid Biopsy Market (by Therapeutic Application), 2017-2028
Figure 9.53    Saudi Arabia: Liquid Biopsy Market, 2017-2028
Figure 9.54    Saudi Arabia: Liquid Biopsy Market (by Therapeutic Application), 2017-2028
Figure 9.55    Rest-of-Latin America and Middle East: Liquid Biopsy Market, 2017-2028
Figure 9.56    Rest-of-the-World: Liquid Biopsy Market, 2017-2028
Figure 10.1    Shares of Key Company Profiles
Figure 10.2    Abcodia Ltd.: Product Offerings for Global Liquid Biopsy Market
Figure 10.3    Abcodia Ltd.: SWOT Analysis
Figure 10.4    Adaptive Biotechnologies: Product Offerings for Global Liquid Biopsy Market
Figure 10.5    Adaptive Biotechnologies: SWOT Analysis
Figure 10.6    ANGLE plc: Product Offerings for Global Liquid Biopsy Market
Figure 10.7    ANGLE plc: Overall Financials, 2015-2017
Figure 10.8    ANGLE plc: Revenue (by Region), 2016 and 2017
Figure 10.9    ANGLE plc: R&D Expense, 2015-2017
Figure 10.10    ANGLE plc: Revenue Forecast, 2015-2020
Figure 10.11    ANGLE plc: Global Presence
Figure 10.12    ANGLE plc: SWOT Analysis
Figure 10.13    Biocept, Inc.: Product Offerings for Global Liquid Biopsy Market
Figure 10.14    Biocept, Inc.: Overall Financials, 2015-2017
Figure 10.15    Biocept, Inc.: R&D Expense, 2015-2017
Figure 10.16    Biocept, Inc.: Revenue Forecast, 2015-2020
Figure 10.17    Biocept, Inc.: SWOT Analysis
Figure 10.18    Bio-Rad Laboratories, Inc.: Product Offerings for Global Liquid Biopsy Market
Figure 10.19    Bio-Rad laboratories, Inc.: Overall Financials, 2015-2017
Figure 10.20    Bio-Rad Laboratories, Inc.: Revenue (by Business Segment), 2015-2017
Figure 10.21    Bio-Rad Laboratories, Inc.: Revenue (by Region), 2015-2017
Figure 10.22    Bio-Rad Laboratories, Inc.: R&D Expense, 2015-2017
Figure 10.23    Bio-Rad Laboratories, Inc.: Revenue Forecast, 2015-2020
Figure 10.24    Bio-Rad Laboratories, Inc.: Global Presence
Figure 10.25    Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 10.26    Cynvenio Biosystems, Inc.: Overall Product Portfolio
Figure 10.27    Cynvenio Biosystems, Inc.: SWOT Analysis
Figure 10.28    Chronix Biomedical: Product Offerings for Global Liquid Biopsy Market
Figure 10.29    Chronix Biomedical: SWOT Analysis
Figure 10.30    Epic Sciences, Inc.: Product Offerings for Global Liquid Biopsy Market
Figure 10.31    Epic Sciences, Inc.: SWOT Analysis
Figure 10.32    F. Hoffmann-La Roche AG: Product Offerings for Global Liquid Biopsy Market
Figure 10.33    F. Hoffmann-La Roche AG: Overall Financials, 2015-2017
Figure 10.34    F. Hoffmann-La Roche AG: Revenue (by Business Segment), 2015-2017
Figure 10.35    F. Hoffmann-La Roche Ltd.: Revenue (by Diagnostics Sub-division), 2015-2017
Figure 10.36    F. Hoffmann-La Roche AG: Revenue (by Region), 2015-2017
Figure 10.37    F. Hoffmann-La Roche AG: R&D Expense, 2015-2017
Figure 10.38    F. Hoffmann-La Roche AG: Revenue Forecast, 2015-2020
Figure 10.39    F. Hoffmann-La Roche AG: Global Presence
Figure 10.40    F. Hoffmann-La Roche AG: SWOT Analysis
Figure 10.41    GUARDANT HEALTH, INC.: Product Offerings for Global Liquid Biopsy Market
Figure 10.42    GUARDANT HEALTH, INC.: SWOT Analysis
Figure 10.43    Illumina, Inc.: Product Offerings for Global Liquid Biopsy Market
Figure 10.44    Illumina, Inc.: Overall Financials, 2015-2017
Figure 10.45    Illumina, Inc.: Revenue (by Business Segment), 2015-2017
Figure 10.46    Illumina, Inc.: Revenue (by Region), 2015-2017
Figure 10.47    Illumina, Inc.: R&D Expense, 2015-2017
Figure 10.48    Illumina, Inc.: Revenue Forecast, 2015-2020
Figure 10.49    Illumina, Inc.: Global Presence
Figure 10.50    Illumina, Inc.: SWOT Analysis
Figure 10.51    MDxHealth, Inc.: Product Offerings for Global Liquid Biopsy Market
Figure 10.52    MDxHealth, Inc.: Overall Financials, 2015-2017
Figure 10.53    MDxHealth, Inc.: R&D Expanse, 2015-2017
Figure 10.54    MDxHealth, Inc.: Revenue Forecast, 2015-2017
Figure 10.55    MDxHealth, Inc.: Global Presence
Figure 10.56    MDxHealth, Inc.: SWOT Analysis
Figure 10.57    Menarini Silicon Biosystems, Inc.: Product Offerings for Global Liquid Biopsy Market
Figure 10.58    Menarini Silicon Biosystems, Inc.: SWOT Analysis
Figure 10.59    Myriad Genetics, Inc.: Product Offerings for Global Liquid Biopsy Market
Figure 10.60    Myriad Genetics, Inc.: Overall Financials, 2015-2017
Figure 10.61    Myriad Genetics, Inc.: Revenue (by Business Segment), 2015-2017
Figure 10.62    Myriad Genetics, Inc.: Revenue (by Region), 2015-2017
Figure 10.63    Myriad Genetics, Inc.: R&D Expense, 2015-2017
Figure 10.64    Myriad Genetics, Inc.: Revenue Forecast, 2015-2020
Figure 10.65    Myriad Genetics, Inc.: Global Presence
Figure 10.66    Myriad Genetics, Inc.: SWOT Analysis
Figure 10.67    Natera, Inc.: Product Offerings for Global Liquid Biopsy Market
Figure 10.68    Natera, Inc.: Overall Financials, 2015-2017
Figure 10.69    Natera, Inc.: Revenue (by Region), 2015-2017
Figure 10.70    Natera, Inc.: R&D Expense, 2015-2017
Figure 10.71    Natera, Inc.: Revenue Forecast, 2015-2020
Figure 10.72    Natera, Inc.: Global Presence
Figure 10.73    Natera, Inc.: SWOT Analysis
Figure 10.74    NeoGenomics Laboratories, Inc.: Product Offerings for Global Liquid Biopsy Market
Figure 10.75    NeoGenomics Laboratories, Inc.: Overall Financials, 2015-2017
Figure 10.76    NeoGenomics Laboratories, Inc.: Revenue (by Business Segment), 2015-2017
Figure 10.77    NeoGenomics Laboratories, Inc.: R&D Expense, 2015-2017
Figure 10.78    NeoGenomics Laboratories, Inc.: Revenue Forecast, 2015-2020
Figure 10.79    NeoGenomics Laboratories, Inc.: Global Presence
Figure 10.80    NeoGenomics Laboratories, Inc.: SWOT Analysis
Figure 10.81    Personal Genome Diagnostics, Inc.: Product Offerings for Global Liquid Biopsy Market
Figure 10.82    Personal Genome Diagnostics, Inc.: SWOT Analysis
Figure 10.83    Qiagen N.V.: Product Offerings for Global Liquid Biopsy Market
Figure 10.84    Qiagen N.V.: Overall Financials, 2015-2017
Figure 10.85    Qiagen N.V.: Revenue (by Business Segment), 2015-2017
Figure 10.86    Qiagen N.V.: Revenue (by Region), 2015-2017
Figure 10.87    Qiagen N.V.: R&D Expense, 2015-2017
Figure 10.88    Qiagen N.V.: Revenue Forecast, 2015-2020
Figure 10.89    Qiagen N.V.: Global Presence
Figure 10.90    Qiagen N.V.: SWOT Analysis
Figure 10.91    Resolution Bioscience, Inc.: Product Offerings for Global Liquid Biopsy Market
Figure 10.92    Resolution Bioscience, Inc.: SWOT Analysis
Figure 10.93    Sysmex Corporation: Product Offerings for Global Liquid Biopsy Market
Figure 10.94    Sysmex Corporation: Overall Financials, 2015-2017
Figure 10.95    Sysmex Corporation: Revenue (by Business Segment), 2016 and 2017
Figure 10.96    Sysmex Corporation: Revenue (by Business Segment), 2015
Figure 10.97    Sysmex Corporation: Revenue by Product Type (2015-2017)
Figure 10.98    Sysmex Corporation: Revenue (by Region), 2015-2017
Figure 10.99    Sysmex Corporation: R&D Expense, 2015-2017
Figure 10.100    Sysmex Corporation: Revenue Forecast, 2015-2020
Figure 10.101    Sysmex Corporation: Global Presence
Figure 10.102    Sysmex Corporation: SWOT Analysis
Figure 10.103    Thermo Fisher Scientific Inc.: Product Offerings for Global Liquid Biopsy Market
Figure 10.104    Thermo Fisher Scientific Inc.: Overall Financials, 2015-2017
Figure 10.105    Thermo Fisher Scientific Inc.: Revenue (by Business Segment), 2015-2017
Figure 10.106    Thermo Fisher Scientific Inc.: Revenue (by Region), 2015-2017
Figure 10.107    Thermo Fisher Scientific Inc.: R&D Expense, 2015-2017
Figure 10.108    Thermo Fisher Scientific Inc.: Revenue Forecast, 2015-2020
Figure 10.109    Thermo Fisher Scientific Inc.: Global Presence
Figure 10.110    Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 11.1    Global Liquid Biopsy: Market Segmentation
Figure 11.2    Global Liquid Biopsy Market Segmentation
Figure 11.3    Primary Research
Figure 11.4    Secondary Research
Figure 11.5    Data Triangulation
Figure 11.6    Top-down Approach (Segment-wise Analysis)
Figure 11.7    Bottom-up Approach (Segment-wise Analysis)
Figure 11.8    Assumptions and Limitations
Figure 11.9    Considered Factors for Data Prediction and Modelling

You may also like

Published Year: 2018

Global Metastatic Cancer Treatment Market : Focus on Drugs, Competitive Landscape, and Country - Ana

The global metastatic cancer treatment market was valued $54.11 billion in 2017, and is...

 
Published Year: 2017

Global Next Generation Sequencing (NGS) Market - Analysis and Forecast (2017-2024) : (Focus on Produ

(Focus on Product Type, Technology, Application, Country Analysis, Market Share Analysis,...

 
Published Year: 2017

Global Precision Medicine Market – Analysis and Forecast (2017-2026): (Focus on Ecosystem Player,

The global precision medicine market was dominated by the oncology segment in 2016. The...

 
Published Year: 2017

In vitro diagnostics (ivd) market, Industry | BIS Research

IVD is expected to increase to $76 billion by 2023 and increase its influence over healthcare...

 

Global Liquid Biopsy Market

Focus on Products and Services, Therapeutic Applications, Clinical Applications, Circulating Biomarkers, Country Analysis (16 Countries), Industry Insights, and Competitive Landscape - Analysis and Forecast, 2018-2028